You participated in our first townhall of 2025 in Q1, at which we got together as ONE Team. On 13 March we get a better overview on all functions, platforms and expert groups among peers in a new format to drive DSO initiatives and digital transformation. POAP dropped for Bayer DT&IT Pharma Design by stefankai with Canva POAP Terms & Conditions: https://bayer.com/poap Bayer IT POAP Collection: https://collections.poap.xyz/bayer-it/

You were invited to our Q4/2024 Townhall, where we explored our future organization based on what has been agreed upon until then. Updates from our Leadership Team included insights from the PH Strategy Summit, which did initiate discussions on our financials and the strategic mid- and long-term outcomes for Pharma. Additionally, we reflected on the results of the Ownership Pulse (formerly known as Employee Voice), discussed further considerations, and allocated time for a Q&A session. This token serves as appreciation for and proof of your participation. POAP dropped for Bayer DT&IT Pharma Design by stefankai with Canva POAP Terms & Conditions: https://bayer.com/poap Bayer IT POAP Collection: https://collections.poap.xyz/bayer-it/

Thank you for attending today's DT & IT Pharma Townhall! In today's meeting, we delved deeper into the successful launch of the Pharma Control Tower (go/PHCT), which serves as a central entry point for all your needs related to financial, operational stability, and governance for your applications, portfolios, and functions. Additionally, we shared some updates on the rollout of MyGenAssist at Pharma, highlighting our crucial role as key ambassadors. This past year has underscored the accelerated pace of innovation, with GenAI standing out as a prime example of the agility needed to proactively evolve our skill sets. Furthermore, we collectively reviewed our key priorities for 2024 and provided updates on our DSO learning journey. In summary: ///// PH Control Tower ///// Business priorities per department ///// MyGenAssist roll-out PH ///// DSO Champions update Bayer terms & conditions apply: https://www.bayer.com/en/poap-tc

Another DSO Open MIC session is in the books! Whether you have attended the morning or afternoon session, without a doubt you have contributed significantly to the success of today's event. These sessions are a space for open exchanges about ongoing topics around DSO and an opportunity to share, ask questions, provide feedback, or just listen. Everyone is invited to attend, participation is voluntary, and the sessions will not be recorded. Bayer terms & conditions apply: https://www.bayer.com/en/poap-tc

World Obesity Day, observed on March 4th, is dedicated to promoting practical solutions to end the global obesity crisis. Obesity, a complex health condition characterized by excessive body fat, is a major risk factor for various diseases, including diabetes, cardiovascular diseases, and certain cancers. Historically, obesity was mostly seen as a symbol of wealth and prosperity. Many of the Venus figurines, made 20,000+ years ago, are corpulent ladies and thought to symbolize fertility, health, and abundance, maybe idealizing body size in times where food scarcity was a constant threat. Ancient medical texts saw it as a health risk, but only in the 20th century research highlighted it as a medical condition. It's caused by a combination of genetic, behavioral, and environmental factors. Poor diet, lack of physical activity, and sedentary lifestyles are key contributors. Obesity affects all age groups and socioeconomic classes, over 10% of the population. However, prevalence rates vary significantly across different regions and populations. In recent years, developing countries have witnessed a rapid rise in obesity rates, a shift attributed to urbanization and changes in lifestyle and dietary habits. Obesity's toll on health, life quality, and economy is huge. World Obesity Day calls for united efforts for change, advocating for healthy lifestyles, supportive policies, and research to combat this challenge. https://en.wikipedia.org/wiki/Obesity Art&Text🫶ChatGPT.